IMPORTANT REMINDER: New DEA Education Requirement on Opioid or other Substance Use Disorders Begins June 27

June 8, 2023

Beginning June 27, DEA license holders, upon initial registration or renewal, will be required to complete at least eight hours of training in the treatment or management of patients with opioid or other substance use disorders. 

To ensure you have the most accurate information, you should review the guidance issued by the DEA. Click here to find the MMA’s recommendations for members who need to complete this training. 

Latest News

House Unanimously Passes MMA Supported Legislation

April 30, 2026

On April 27, the House unanimously passed a bill authorizing trained pharmacists to initiate, prescribe, dispense, and administer buprenorphine for the treatment of opioid use disorder. 

House Passes APRN Scope of Practice Bill Despite MMA Opposition

April 30, 2026

On April 27, the House passed a bill, with a 119-12 vote, that removes the current requirement that newly licensed Advanced Practice Registered Nurses (APRNs) complete 2,080 hours of collaborative practice with a physician as part of their postgraduate training before practicing independently. 

Providers Receiving First Batch of Outstanding UCare Payments

April 30, 2026

Last November, UCare announced it would be shutting its doors in 2026, leaving many providers with outstanding claims that had not been paid out.